Literature DB >> 26561079

Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn's Disease and Ulcerative Colitis.

Alyssa Parian1, Berkeley N Limketkai.   

Abstract

Inflammatory bowel disease (IBD) including ulcerative colitis and Crohn's disease are chronic relapsing and remitting chronic diseases for which there is no cure. The treatment of IBD frequently requires immunosuppressive and biologic therapies which carry an increased risk of infections and possible malignancy. There is a continued search for safer and more natural therapies in the treatment of IBD. This review aims to summarize the most current literature on the use of dietary supplements for the treatment of IBD. Specifically, the efficacy and adverse effects of vitamin D, fish oil, probiotics, prebiotics, curcumin, Boswellia serrata, aloe vera and cannabis sativa are reviewed.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26561079     DOI: 10.2174/1381612822666151112145033

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  13 in total

Review 1.  Design and implementation of novel nutraceuticals and derivatives for treating intestinal disorders.

Authors:  Maria J Barahona; Vanessa Baratta; Jenna Ollodart; David Mulligan; John P Geibel
Journal:  Future Med Chem       Date:  2019-04-17       Impact factor: 3.808

2.  Specific immunotherapy plus Clostridium butyricum alleviates ulcerative colitis in patients with food allergy.

Authors:  Fan Yang; Dong Lu; Zhenlv Lin
Journal:  Sci Rep       Date:  2016-05-11       Impact factor: 4.379

3.  Dietary Creatine as a Possible Novel Treatment for Crohn's Ileitis.

Authors:  Abhik Roy; David Lee
Journal:  ACG Case Rep J       Date:  2016-12-07

Review 4.  Potential role of nutraceutical compounds in inflammatory bowel disease.

Authors:  Tiziana Larussa; Maria Imeneo; Francesco Luzza
Journal:  World J Gastroenterol       Date:  2017-04-14       Impact factor: 5.742

Review 5.  Mutual Two-Way Interactions of Curcumin and Gut Microbiota.

Authors:  Ryszard Pluta; Sławomir Januszewski; Marzena Ułamek-Kozioł
Journal:  Int J Mol Sci       Date:  2020-02-05       Impact factor: 5.923

6.  Improvement of Oxazolone-Induced Ulcerative Colitis in Rats Using Andrographolide.

Authors:  Liuhong Zhang; Ning Cao; Yuwen Wang; Youxu Wang; Chao Wu; Xuemei Cheng; Changhong Wang
Journal:  Molecules       Date:  2019-12-24       Impact factor: 4.411

7.  Safety evaluation of Aloe vera soft capsule in acute, subacute toxicity and genotoxicity study.

Authors:  Jun Wu; Ying Zhang; Zhongming Lv; Ping Yu; Weiqing Shi
Journal:  PLoS One       Date:  2021-03-26       Impact factor: 3.240

8.  Icariin Inhibits Intestinal Inflammation of DSS-Induced Colitis Mice Through Modulating Intestinal Flora Abundance and Modulating p-p65/p65 Molecule.

Authors:  Haoran Zhang; Shixuan Zhuo; Danni Song; Leyao Wang; Junyi Gu; Junyan Ma; Yang Gu; Minghui Ji; Meijuan Chen; Yuanyuan Guo
Journal:  Turk J Gastroenterol       Date:  2021-04       Impact factor: 1.852

Review 9.  Considerations to Be Taken When Carrying Out Medicinal Plant Research-What We Learn from an Insight into the IC50 Values, Bioavailability and Clinical Efficacy of Exemplary Anti-Inflammatory Herbal Components.

Authors:  Mona Abdel-Tawab
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-06

Review 10.  Gut Microbiota as a Prospective Therapeutic Target for Curcumin: A Review of Mutual Influence.

Authors:  Wissam Zam
Journal:  J Nutr Metab       Date:  2018-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.